美國居民不適用 XM 服務。

3M, Corteva, Chemours hit with class action over 'forever chemicals' in carpet



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>3M, Corteva, Chemours hit with class action over 'forever chemicals' in carpet</title></head><body>

By Brendan Pierson

Aug 30 (Reuters) -3M MMM.N, Corteva CTVA.N and Chemours CC.N were hit with a class action lawsuit on Friday accusing them of covering up the health risks of so-called "forever chemicals" used in carpets and rugs nationwide.

The lawsuit, filed in Minnesota federal court, seeks to represent a class of everyone in the United States who bought and installed carpets before 2020 in buildings they own. It alleges that per- and polyfluoroalkyl substances, or PFAS, made by the defendants, were used in "virtually all" carpets up to that time for stain and water resistance.

The lawsuit is seeking economic damages to remove and replace contaminated carpets, as well as punitive damages, but does not include personal injury claims.

It accuses the companies of violating the Racketeer Influenced and Corrupt Organizations Act (RICO), a federal law originally targeting organized crime that also allows civil claims over alleged conspiracies. It also includes numerous claims under state consumer protection laws, and common law claims of nuisance, failure to warn and design defect.

"As the science and technology of PFAS, societal and regulatory expectations, and our expectations of ourselves have evolved, so has how we manage PFAS," 3M said in a statement. "3M will address PFAS litigation by defending itself in court or through negotiated resolutions, all as appropriate."

Corteva and Chemours, which are both spinoffs of DuPont DD.N, did not immediately respond to requests for comment.

PFAS are a family of thousands of chemicals used in consumer and commercial products like firefighting foams, nonstick pans and stain resistant fabrics. They have been linked to cancer and other health concerns and are often called forever chemicals because they do not easily break down in the human body or the environment.

Friday's lawsuit says that DuPont learned as early as the 1950s that PFAS in its Teflon non-stick products were toxic, but kept the knowledge from the public, and that the defendants continued working to cover up the risks. 3M for years secretly paid a toxicology professor to review articles submitted to academic journals and keep research about the dangers of PFAS from being published, it said.

The United States has recently tightened regulation of PFAS, unveiling new standards for contamination in drinking water and requiring some PFAS contamination to be cleaned up under the federal Superfund program for hazardous sites.

Thousands of lawsuits have been filed in recent years against manufacturers of PFAS and the companies that use the chemicals to create a diverse array of products.

DuPont, Corteva and Chemours last year agreed to pay a combined $1.19 billion to public water systems to resolve claims over PFAS contamination, and 3M agreed to pay $10.3 billion.

The case is Peterson et al v. 3M et al, U.S. District Court for the District of Minnesota, No. 0:24-cv-03497.

For plaintiffs: Steve Berman of Hagens Berman Sobol Shapiro and others

For defendants: not available


Read more:

US sets first standard to curb 'forever chemicals' from drinking water

US designates PFAS chemicals as Superfund hazardous substances

Chemical makers settle PFAS-related claims for $1.19 billion

3M reaches tentative $10.3 billion deal over US 'forever chemicals' claims


</body></html>

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明